Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Microdose Medication ™ logo — Pioneering targeted treatments for neurodegenerative and psy...

Microdose Medication ™

Pioneering targeted treatments for neurodegenerative and psychiatric disorders with advanced psychedelic drug delivery technology.

Founded 2022 2-10 employees Health Care, Pharmaceutical

General Information

Company Name Microdose Medication ™
Founded Year 2022
Employees 2-10
Industries Health Care, Pharmaceutical
Social

Get notified when Microdose Medication ™ moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Microdose Medication ™

Microdose Medication ™ is a pioneering startup focusing on the development of psychedelic-based medications. Their nanotechnology-driven approach aims to create advanced treatments targeting severe neurodegenerative diseases and emerging psychiatric disorders. The company, founded in 2022 and based in the United Kingdom, holds a patent-pending technology for psychedelic drug delivery in clinical settings. With a mission to revolutionize treatment in the health care and pharmaceutical industries, Microdose Medication™ is a compelling force in the evolving landscape of medical innovation.

Taxonomy: Psychedelic drug delivery, Neurodegenerative disorders, Psychiatric disorders, Deuterated treatments, Nanotechnology, Drug development, Clinical environments, UK-based company

No funding data available for Microdose Medication ™ yet.

Get notified when Microdose Medication ™ raises funding

Microdose Medication ™ Alternatives & Competitors

Microdose Medication ™ vs
Biomind Labs Inc.
Biomind Labs Inc. Canada

The next generation of pharma.

6 employees
Microdose Medication ™ vs
Tryp Therapeutics
Tryp Therapeutics Australia

Tryp is leading the next wave of psychedelic drug development.

Post Ipo Equity
9 employees
Biotechnology
Microdose Medication ™ vs
Beckley Psytech
Beckley Psytech United Kingdom

Transforming psychedelics into effective and rapid-acting medicines for neuropsychiatric conditions.

Merged
68 employees

FAQ About Microdose Medication ™

Pioneering targeted treatments for neurodegenerative and psychiatric disorders with advanced psychedelic drug delivery technology.
Microdose Medication ™ was founded in 2022.
Microdose Medication ™ operates in the following industries: Health Care, Pharmaceutical.
Microdose Medication ™ has approximately 2-10 employees.
Top alternatives and competitors to Microdose Medication ™ include Biomind Labs Inc., Tryp Therapeutics, Beckley Psytech, Mindstate Design Labs, Delix Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Microdose Medication ™ and Biomind Labs Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Microdose Medication ™ and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy